Parents can't sue drug firms when vaccines cause harm, Supreme Court says
A federal law grants drug companies immunity from certain lawsuits from injuries or deaths tied to vaccines, the US Supreme Court affirmed Tuesday.
(Page 2 of 2)
The key issue in the case was why Congress did not mention “defective design” as preempted from potential lawsuits.
Skip to next paragraphThe majority justices read the law to sweep broadly, preempting any and all design defect claims provided that the manufacturing process did not create a defect and that warnings and directions were adequate.
“If a manufacturer could be held liable for failure to use a different design, the word ‘unavoidable’ would do not work,” Justice Scalia wrote. “A side effect of a vaccine could always have been avoidable by use of a differently designed vaccine not containing the harmful element.”
He added: “The language of the provision thus suggests that the design of the vaccine is a given, not subject to question in the tort action.” The design itself may not be the subject of a vaccine lawsuit, the court ruled.
In their dissent, Justices Sotomayor and Ginsburg adopted a narrow reading of the statute’s preemption provision. They said Congress intended that vaccinemakers would continue to face the prospect of design-defect lawsuits filed by victims.
In rejecting broad preemption for design defects, the dissenters said, Congress intended for drugmakers to face a continuing “legal duty” to improve the designs of their vaccines in light of advances in science and technology. The high court action on Tuesday eliminated that duty, they said.
“Manufacturers, given the lack of robust competition in the vaccine market, will often have little or no incentive to improve the designs of vaccines that are already generating significant profit margins,” Sotomayor wrote. “Nothing in the text, structure, or legislative history remotely suggests that Congress intended that result.”
The high court decision stems from the April 1992 administration of a vaccine to the Bruesewitzes' then-infant daughter, Hannah. After being injected with the diphtheria-tetanus-pertussis (DTP) vaccine, Hannah suffered a series of seizures that left her developmentally disabled. Lawyers for the family say she will require medical care and supervision throughout her life.
The Bruesewitzes took their claim to the special Vaccine Court, but a month before they filed their petition, Hannah’s seizure disorder was dropped from a listing of injuries covered under the Vaccine Injury Act. The Vaccine Court ruled that the family would receive no compensation.
The family then filed suit in state court alleging that Wyeth Inc., the vaccine manufacturer, was negligent because it could have produced a safer version of the vaccine, but failed to do so. Lawyers for the family argued that the company should have upgraded its vaccine with a less dangerous version.
Wyeth lawyers countered that the federal Vaccine Injury Act preempts such claims made in state court.
The case was moved to federal court, where a judge agreed with Wyeth and ruled that the state lawsuit was preempted by federal law. The Third US Circuit Court of Appeals affirmed. In its ruling on Tuesday, the high court upheld the Third Circuit decision.
Justice Elena Kagan took no part in the case.
How much do you know about the US Constitution? A quiz.



Previous







These comments are not screened before publication. Constructive debate about the above story is welcome, but personal attacks are not. Please do not post comments that are commercial in nature or that violate any copyright[s]. Comments that we regard as obscene, defamatory, or intended to incite violence will be removed. If you find a comment offensive, you may flag it.